Mountain View, CA, United States of America

Douglas Kenneth Rabert


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2001-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Douglas Kenneth Rabert: Innovator in Sodium Channel Research

Introduction

Douglas Kenneth Rabert is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of neuroscience through his innovative research on sodium channels. With a total of 3 patents, Rabert's work focuses on developing therapeutic targets for disorders of the peripheral nervous system.

Latest Patents

Rabert's latest patents include a method of modulating tetrodotoxin-resistant sodium channels. This invention relates to a voltage-gated sodium channel found in peripheral nerve tissue that is resistant to tetrodotoxin. One aspect of this invention involves purified and isolated DNA encoding this sodium channel. Additionally, it encompasses the recombinant protein expressed by this DNA, expression vectors containing the DNA sequence, and host cells transformed with these expression vectors. The invention aims to utilize this voltage-gated, tetrodotoxin-resistant sodium channel as a therapeutic target for compounds designed to treat disorders of the peripheral nervous system.

Career Highlights

Douglas Kenneth Rabert is associated with Syntex (U.S.A.) Inc., where he has been able to apply his expertise in sodium channel research. His work has contributed to advancements in understanding and treating peripheral nervous system disorders.

Collaborations

Rabert has collaborated with notable colleagues, including Ronald Herman and Stephen Gregory Delgado. Their combined efforts have furthered research in the field and enhanced the impact of their innovations.

Conclusion

Douglas Kenneth Rabert's contributions to sodium channel research highlight his role as an influential inventor in the field of neuroscience. His innovative patents and collaborations continue to pave the way for advancements in therapeutic treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…